HC Wainwright Forecasts Cytosorbents FY2028 Earnings
Analysts at HC Wainwright issued their FY2028 earnings per share estimates for shares of Cytosorbents in a research note issued to investors on Thursday, April 3rd. HC Wainwright analyst S. Lee ...
HC Wainwright Reaffirms Buy Rating for Akebia Therapeutics (NASDAQ:AKBA)
Akebia Therapeutics (NASDAQ:AKBA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Friday,Benzinga reports.